Uncertainty about whether they will get paid not to work through September is deterring employees who face a Thursday ...
Eli Lilly reported mixed results for the fourth quarter, even as demand for its blockbuster weight loss drug Zepbound and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results